Synopsis of recent research by authors named "Shuwei Hu"
- Shuwei Hu's recent research focuses on the interplay between metabolic dysfunction and the regulation of lipid metabolism, particularly in conditions like metabolic dysfunction-associated steatohepatitis (MASH), underscoring the role of specific transcription factors such as ATF3 and KLF10.
- Hu has investigated pharmacokinetics and metabolism of therapeutic agents such as the SARS-CoV-2 protease inhibitor simnotrelvir, utilizing advanced analytical techniques like F qNMR and LC-MS/MS to improve drug efficacy and safety.
- Additionally, Hu's research extends to public health concerns, examining the prevalence of neuropsychological comorbidities in low birth weight children, as well as the broader implications of metabolic regulation in cancer treatment using innovative nanomaterials for therapeutic applications.
